Advertisement
Screener

ANIXA BIOSCIENCES, INC. (ANIX) Operating Income

ANIXA BIOSCIENCES, INC. Operating Income

ANIXA BIOSCIENCES, INC. (ANIX) reported Operating Income of -$2.74 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-09.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-09-09

  • ANIXA BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-07-31 was -$2.74M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-04-30 was -$2.65M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-01-31 was -$2.72M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for the quarter ending 2025-10-31 was -$2.88M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for fiscal 2025 was -$11.70M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for fiscal 2024 was -$13.83M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for fiscal 2023 was -$11.01M.
  • ANIXA BIOSCIENCES, INC. operating income (loss) for fiscal 2022 was -$13.88M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2026-07-31-$2.74M
10-Q · filed 2026-09-09
-$5.38M
derived: sum of 2 quarters · filed 2026-09-09
-$8.10M
10-Q · filed 2026-09-09
-$10.98M
derived: sum of 4 quarters · filed 2026-09-09
2026-04-30-$2.65M
10-Q · filed 2026-06-10
-$5.36M
10-Q · filed 2026-06-10
-$8.24M
derived: sum of 3 quarters · filed 2026-06-10
-$10.68M
derived: sum of 4 quarters · filed 2026-09-09
2026-01-31-$2.72M
10-Q · filed 2026-03-09
-$5.59M
derived: sum of 2 quarters · filed 2026-03-09
-$8.03M
derived: sum of 3 quarters · filed 2026-09-09
-$11.03M
derived: sum of 4 quarters · filed 2026-09-09
2025-10-31-$2.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12
-$5.31M
derived: sum of 2 quarters · filed 2026-09-09
-$8.31M
derived: sum of 3 quarters · filed 2026-09-09
-$11.70M
10-K · filed 2026-01-12
2025-07-31-$2.44M
10-Q · filed 2026-09-09
-$5.44M
derived: sum of 2 quarters · filed 2026-09-09
-$8.82M
10-Q · filed 2026-09-09
-$11.99M
derived: sum of 4 quarters · filed 2026-09-09
2025-04-30-$3.00M
10-Q · filed 2026-06-10
-$6.39M
10-Q · filed 2026-06-10
-$9.55M
derived: sum of 3 quarters · filed 2026-06-10
-$13.14M
derived: sum of 4 quarters · filed 2026-06-10
2025-01-31-$3.39M
10-Q · filed 2026-03-09
-$6.55M
derived: sum of 2 quarters · filed 2026-03-09
-$10.14M
derived: sum of 3 quarters · filed 2026-03-09
-$13.61M
derived: sum of 4 quarters · filed 2026-03-09
2024-10-31-$3.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12
-$6.75M
derived: sum of 2 quarters · filed 2026-01-12
-$10.22M
derived: sum of 3 quarters · filed 2026-01-12
-$13.83M
10-K · filed 2026-01-12
2024-07-31-$3.59M
10-Q · filed 2025-09-10
-$7.06M
derived: sum of 2 quarters · filed 2025-09-10
-$10.67M
10-Q · filed 2025-09-10
-$13.72M
derived: sum of 4 quarters · filed 2025-09-10
2024-04-30-$3.47M
10-Q · filed 2025-05-28
-$7.08M
10-Q · filed 2025-05-28
-$10.13M
derived: sum of 3 quarters · filed 2025-05-28
-$12.97M
derived: sum of 4 quarters · filed 2025-05-28
2024-01-31-$3.61M
10-Q · filed 2025-03-11
-$6.66M
derived: sum of 2 quarters · filed 2025-03-11
-$9.50M
derived: sum of 3 quarters · filed 2025-03-11
-$12.06M
derived: sum of 4 quarters · filed 2025-03-11
2023-10-31-$3.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10
-$5.89M
derived: sum of 2 quarters · filed 2025-01-10
-$8.46M
derived: sum of 3 quarters · filed 2025-01-10
-$11.01M
10-K · filed 2025-01-10
2023-07-31-$2.84M
10-Q · filed 2024-09-06
-$5.40M
derived: sum of 2 quarters · filed 2024-09-06
-$7.96M
10-Q · filed 2024-09-06
-$11.57M
derived: sum of 4 quarters · filed 2024-09-06
2023-04-30-$2.56M
10-Q · filed 2024-06-04
-$5.12M
10-Q · filed 2024-06-04
-$8.72M
derived: sum of 3 quarters · filed 2024-06-04
-$11.52M
derived: sum of 4 quarters · filed 2024-06-04
2023-01-31-$2.56M
10-Q · filed 2024-03-12
-$6.17M
derived: sum of 2 quarters · filed 2024-03-12
-$8.96M
derived: sum of 3 quarters · filed 2024-03-12
-$12.55M
derived: sum of 4 quarters · filed 2024-03-12
2022-10-31-$3.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-16
-$6.41M
derived: sum of 2 quarters · filed 2024-01-16
-$9.99M
derived: sum of 3 quarters · filed 2024-01-16
-$13.88M
10-K · filed 2024-01-16
2022-07-31-$2.80M
10-Q · filed 2023-09-06
-$6.39M
derived: sum of 2 quarters · filed 2023-09-06
-$10.27M
10-Q · filed 2023-09-06
-$14.34M
derived: sum of 4 quarters · filed 2023-09-06
2022-04-30-$3.59M
10-Q · filed 2023-06-14
-$7.47M
10-Q · filed 2023-06-14
-$11.55M
derived: sum of 3 quarters · filed 2023-06-14
-$15.93M
derived: sum of 4 quarters · filed 2023-06-14
2022-01-31-$3.88M
10-Q · filed 2023-03-17
-$7.96M
derived: sum of 2 quarters · filed 2023-03-17
-$12.35M
derived: sum of 3 quarters · filed 2023-03-17
-$14.78M
derived: sum of 4 quarters · filed 2023-03-17
2021-10-31-$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-04
-$8.46M
derived: sum of 2 quarters · filed 2023-01-04
-$10.90M
derived: sum of 3 quarters · filed 2023-01-04
-$13.14M
10-K · filed 2023-01-04
-$13.14M
10-K · filed 2022-01-04
2021-07-31-$4.39M
10-Q · filed 2022-09-09
-$4.39M
10-Q · filed 2021-09-01
-$6.83M
derived: sum of 2 quarters · filed 2022-09-09
-$9.06M
10-Q · filed 2022-09-09
-$9.06M
10-Q · filed 2021-09-01
-$11.30M
derived: sum of 4 quarters · filed 2022-09-09
2021-04-30-$2.44M
10-Q · filed 2022-06-10
-$2.44M
10-Q · filed 2021-06-10
-$4.67M
10-Q · filed 2022-06-10
-$4.67M
10-Q · filed 2021-06-10
-$6.91M
derived: sum of 3 quarters · filed 2022-06-10
-$9.35M
derived: sum of 4 quarters · filed 2022-06-10
2021-01-31-$2.23M
10-Q · filed 2022-03-11
-$2.23M
10-Q · filed 2021-03-11
-$4.48M
derived: sum of 2 quarters · filed 2022-03-11
-$6.91M
derived: sum of 3 quarters · filed 2022-03-11
-$9.58M
derived: sum of 4 quarters · filed 2022-03-11
2020-10-31-$2.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-01-04
-$4.68M
derived: sum of 2 quarters · filed 2022-01-04
-$7.35M
derived: sum of 3 quarters · filed 2022-01-04
-$9.98M
10-K · filed 2022-01-04
2020-07-31-$2.44M
10-Q · filed 2021-09-01
-$5.11M
derived: sum of 2 quarters · filed 2021-09-01
-$7.74M
10-Q · filed 2021-09-01
-$9.86M
derived: sum of 4 quarters · filed 2021-09-01
2020-04-30-$2.67M
10-Q · filed 2021-06-10
-$5.30M
10-Q · filed 2021-06-10
-$7.43M
derived: sum of 3 quarters · filed 2021-06-10
-$9.61M
derived: sum of 4 quarters · filed 2021-06-10
2020-01-31-$2.63M
10-Q · filed 2021-03-11
-$4.76M
derived: sum of 2 quarters · filed 2021-03-11
-$6.94M
derived: sum of 3 quarters · filed 2021-03-11
-$9.54M
derived: sum of 4 quarters · filed 2021-03-11
2019-10-31-$2.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07
-$4.31M
derived: sum of 2 quarters · filed 2021-01-07
-$6.91M
derived: sum of 3 quarters · filed 2021-01-07
-$11.89M
10-K · filed 2021-01-07
2019-07-31-$2.18M
10-Q · filed 2020-09-08
-$4.78M
derived: sum of 2 quarters · filed 2020-09-08
-$9.76M
10-Q · filed 2020-09-08
-$15.17M
derived: sum of 4 quarters · filed 2020-09-08
2019-04-30-$2.59M
10-Q · filed 2020-06-09
-$7.58M
10-Q · filed 2020-06-09
-$12.98M
derived: sum of 3 quarters · filed 2020-06-09
-$18.59M
derived: sum of 4 quarters · filed 2020-06-09
2019-01-31-$4.98M
10-Q · filed 2020-03-09
-$10.39M
derived: sum of 2 quarters · filed 2020-03-09
-$16.00M
derived: sum of 3 quarters · filed 2020-03-09
-$17.40M
derived: sum of 4 quarters · filed 2020-03-09
2018-10-31-$5.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09
-$11.01M
derived: sum of 2 quarters · filed 2020-01-09
-$12.41M
derived: sum of 3 quarters · filed 2020-01-09
-$14.29M
10-K · filed 2020-01-09
2018-07-31-$5.61M
10-Q · filed 2019-09-06
-$7.01M
derived: sum of 2 quarters · filed 2019-09-06
-$8.88M
10-Q · filed 2019-09-06
-$10.62M
derived: sum of 4 quarters · filed 2019-09-06
2018-04-30-$1.40M
10-Q · filed 2019-06-12
-$3.28M
10-Q · filed 2019-06-12
-$5.01M
derived: sum of 3 quarters · filed 2019-06-12
-$6.74M
derived: sum of 4 quarters · filed 2019-06-12
2018-01-31-$1.87M
10-Q · filed 2019-03-13
-$3.61M
derived: sum of 2 quarters · filed 2019-03-13
-$5.34M
derived: sum of 3 quarters · filed 2019-03-13
-$6.56M
derived: sum of 4 quarters · filed 2019-03-13
2017-10-31-$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11
-$3.47M
derived: sum of 2 quarters · filed 2019-01-11
-$4.68M
derived: sum of 3 quarters · filed 2019-01-11
-$6.08M
10-K · filed 2019-01-11
2017-07-31-$1.73M
10-Q · filed 2018-09-07
-$2.94M
derived: sum of 2 quarters · filed 2018-09-07
-$4.34M
10-Q · filed 2018-09-07
-$5.25M
derived: sum of 4 quarters · filed 2018-09-07
2017-04-30-$1.21M
10-Q · filed 2018-06-11
-$2.61M
10-Q · filed 2018-06-11
-$3.52M
derived: sum of 3 quarters · filed 2018-06-11
-$4.50M
derived: sum of 4 quarters · filed 2018-06-11
2017-01-31-$1.39M
10-Q · filed 2018-03-09
-$2.31M
derived: sum of 2 quarters · filed 2018-03-09
-$3.28M
derived: sum of 3 quarters · filed 2018-03-09
-$4.43M
derived: sum of 4 quarters · filed 2018-03-09
2016-10-31-$913.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09
-$1.89M
derived: sum of 2 quarters · filed 2018-01-09
-$3.04M
derived: sum of 3 quarters · filed 2018-01-09
-$4.51M
10-K · filed 2018-01-09
2016-07-31-$974.88K
10-Q · filed 2017-09-08
-$2.12M
derived: sum of 2 quarters · filed 2017-09-08
-$3.60M
10-Q · filed 2017-09-08
-$4.77M
derived: sum of 4 quarters · filed 2017-09-08
2016-04-30-$1.15M
10-Q · filed 2017-05-26
-$2.62M
10-Q · filed 2017-05-26
-$3.80M
derived: sum of 3 quarters · filed 2017-05-26
-$5.29M
derived: sum of 4 quarters · filed 2017-05-26
2016-01-31-$1.47M
10-Q · filed 2017-03-16
-$2.65M
derived: sum of 2 quarters · filed 2017-03-16
-$4.14M
derived: sum of 3 quarters · filed 2017-03-16
-$6.27M
derived: sum of 4 quarters · filed 2017-03-16
2015-10-31-$1.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08
-$2.67M
derived: sum of 2 quarters · filed 2016-12-08
-$4.80M
derived: sum of 3 quarters · filed 2016-12-08
-$944.76K
10-K · filed 2016-12-08
2015-07-31-$1.49M
10-Q · filed 2016-08-19
-$3.62M
derived: sum of 2 quarters · filed 2016-08-19
$232.77K
10-Q · filed 2016-08-19
-$1.33M
derived: sum of 4 quarters · filed 2016-08-19
2015-04-30-$2.13M
10-Q · filed 2016-05-20
$1.72M
10-Q · filed 2016-05-20
$159.02K
derived: sum of 3 quarters · filed 2016-05-20
-$565.00
derived: sum of 4 quarters · filed 2016-05-20
2015-01-31$3.86M
10-Q · filed 2016-02-19
$2.29M
derived: sum of 2 quarters · filed 2016-02-19
$2.13M
derived: sum of 3 quarters · filed 2016-02-19
$777.40K
derived: sum of 4 quarters · filed 2016-02-19
2014-10-31-$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23
-$1.72M
derived: sum of 2 quarters · filed 2015-12-23
-$3.08M
derived: sum of 3 quarters · filed 2015-12-23
-$5.04M
10-K · filed 2015-12-23
2014-07-31-$159.58K
10-Q · filed 2015-08-18
-$1.51M
derived: sum of 2 quarters · filed 2015-08-18
-$3.48M
10-Q · filed 2015-08-18
-$5.25M
derived: sum of 4 quarters · filed 2015-08-18
2014-04-30-$1.36M
10-Q · filed 2015-05-22
-$3.32M
10-Q · filed 2015-05-22
-$5.10M
derived: sum of 3 quarters · filed 2015-05-22
-$7.31M
derived: sum of 4 quarters · filed 2015-05-22
2014-01-31-$1.96M
10-Q · filed 2015-03-09
-$3.74M
derived: sum of 2 quarters · filed 2015-03-09
-$5.96M
derived: sum of 3 quarters · filed 2015-03-09
-$7.81M
derived: sum of 4 quarters · filed 2015-03-09
2013-10-31-$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29
-$3.99M
derived: sum of 2 quarters · filed 2015-01-29
-$5.84M
derived: sum of 3 quarters · filed 2015-01-29
-$7.92M
10-K · filed 2015-01-29
2013-07-31-$2.22M
10-Q · filed 2014-09-15
-$4.07M
derived: sum of 2 quarters · filed 2014-09-15
-$6.14M
10-Q · filed 2014-09-15
-$7.87M
derived: sum of 4 quarters · filed 2014-09-15
2013-04-30-$1.85M
10-Q · filed 2014-06-16
-$3.92M
10-Q · filed 2014-06-16
-$5.65M
derived: sum of 3 quarters · filed 2014-06-16
-$6.29M
derived: sum of 4 quarters · filed 2014-06-16
2013-01-31-$2.07M
10-Q · filed 2014-03-17
-$3.80M
derived: sum of 2 quarters · filed 2014-03-17
-$4.44M
derived: sum of 3 quarters · filed 2014-03-17
-$5.32M
derived: sum of 4 quarters · filed 2014-03-17
2012-10-31-$1.73M
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17
-$2.37M
derived: sum of 2 quarters · filed 2014-01-17
-$3.25M
derived: sum of 3 quarters · filed 2014-01-17
-$4.13M
10-K/A · filed 2014-01-17
2012-07-31-$643.34K
10-Q/A · filed 2013-09-20
-$1.52M
derived: sum of 2 quarters · filed 2013-09-20
-$2.41M
10-Q/A · filed 2013-09-20
-$3.42M
derived: sum of 4 quarters · filed 2013-09-20
2012-04-30-$878.20K
10-Q/A · filed 2013-06-19
-$1.77M
10-Q/A · filed 2013-06-19
-$2.77M
derived: sum of 3 quarters · filed 2013-06-19
-$3.98M
derived: sum of 4 quarters · filed 2013-06-19
2012-01-31-$887.26K
10-Q/A · filed 2013-03-25
-$1.89M
derived: sum of 2 quarters · filed 2013-03-25
-$3.10M
derived: sum of 3 quarters · filed 2013-03-25
-$4.39M
derived: sum of 4 quarters · filed 2013-03-25
2011-10-31-$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29
-$2.21M
derived: sum of 2 quarters · filed 2013-01-29
-$3.50M
derived: sum of 3 quarters · filed 2013-01-29
-$5.03M
10-K · filed 2013-01-29
2011-07-31-$1.21M
10-Q · filed 2012-09-14
-$2.50M
derived: sum of 2 quarters · filed 2012-09-14
-$4.02M
10-Q · filed 2012-09-14
-$5.15M
derived: sum of 4 quarters · filed 2012-09-14
2011-04-30-$1.29M
10-Q · filed 2012-06-14
-$2.81M
10-Q · filed 2012-06-14
-$3.94M
derived: sum of 3 quarters · filed 2012-06-14
-$5.21M
derived: sum of 4 quarters · filed 2012-06-14
2011-01-31-$1.53M
10-Q · filed 2012-03-16
-$2.65M
derived: sum of 2 quarters · filed 2012-03-16
-$3.92M
derived: sum of 3 quarters · filed 2012-03-16
2010-10-31-$1.13M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30
-$2.40M
derived: sum of 2 quarters · filed 2012-01-30
-$5.25M
10-K · filed 2012-01-30
2010-07-31-$1.27M
10-Q/A · filed 2011-10-14
-$4.12M
10-Q/A · filed 2011-10-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ProMIS Neurosciences Inc. (PMN)$0.102B
Rallybio Corp (RLYB)United States$0.089B
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92